bioMérieux Group Operating company HQ: France
bioMérieux Group has been party to twelve Unified Patent Court cases, 6 times as claimant and 6 times as respondent. The most recent on record is UPC CoA 47/2026 at the Court of Appeal. Its most recent decision on the merits was in UPC CFI 315/2024 at the Dusseldorf Local Division on 28 January 2026: no infringement found.
Labrador Diagnostics LLC 7 More opponents
2026-03-27 UPC CoA 47/2026 Court of Appeal — Labrador Diagnostics LLC v bioMérieux SA 2025-12-23 UPC CoA 937/2025 Court of Appeal Procedural only bioMérieux Benelux BV v Labrador Diagnostics LLC 2025-12-23 UPC CoA 938/2025 Court of Appeal Procedural only bioMérieux UK Limited v Labrador Diagnostics LLC 2025-06-10 UPC CFI 497/2025 Dusseldorf LD Withdrawn bioMérieux Deutschland GmbH v QIAGEN Australia Holdings PTY Ltd. 2025-06-10 UPC CFI 516/2025 Dusseldorf LD Withdrawn bioMérieux Deutschland GmbH v QIAGEN Sciences, LLC 2025-02-28 UPC CFI 181/2025 Dusseldorf LD Withdrawn QIAGEN Sciences, LLC v bioMérieux SA 2024-09-30 UPC CFI 497/2024 Milan CD Patent upheld as amended bioMérieux UK Limited v Labrador Diagnostics LLC 2024-09-30 UPC CFI 571/2024 Milan CD Patent upheld as amended bioMérieux Benelux BV v Labrador Diagnostics LLC 2024-06-13 UPC CFI 315/2024 Dusseldorf LD No infringement Labrador Diagnostics LLC v bioMérieux SA — CC 54050/2024 Milan CD Procedural only Labrador Diagnostics LLC v bioMérieux SA